{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:34:49Z","timestamp":1780590889495,"version":"3.54.1"},"reference-count":119,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.suc.2020.02.009","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T17:50:40Z","timestamp":1587059440000},"page":"589-613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Peritoneal Cancers and Hyperthermic Intraperitoneal Chemotherapy"],"prefix":"10.1016","volume":"100","author":[{"given":"Eric","family":"Pletcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Labow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suc.2020.02.009_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/path.1700120212","article-title":"Malignant tumor arising from endothelium of peritoneum, and producing mucoid ascitic fluid","volume":"12","author":"Miller","year":"1908","journal-title":"J\u00a0Pathol Bacteriol"},{"issue":"4","key":"10.1016\/j.suc.2020.02.009_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archsurg.1980.01380040037006","article-title":"Pseudomyxoma peritonei","volume":"115","author":"Fernandez","year":"1980","journal-title":"Arch Surg"},{"key":"10.1016\/j.suc.2020.02.009_bib3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0002-9343(80)90103-5","article-title":"Multimodality therapy for malignant mesothelioma based on a study of natural history","volume":"68","author":"Antman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.suc.2020.02.009_bib4","first-page":"1","article-title":"Theoretical and experimental bases of intraperitoneal chemotherapy","volume":"12","author":"Dedrick","year":"1985","journal-title":"Semin Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2020.02.009_bib6","first-page":"935","article-title":"Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005","volume":"20","author":"Moolgavkar","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.suc.2020.02.009_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/2049396712Y.0000000016","article-title":"Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003-2008","volume":"19","author":"Henley","year":"2013","journal-title":"Int J Occup Environ Health"},{"key":"10.1016\/j.suc.2020.02.009_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1096-9098(199901)70:1<6::AID-JSO2>3.0.CO;2-X","article-title":"Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma","volume":"70","author":"Eltabbakh","year":"1999","journal-title":"J\u00a0Surg Oncol"},{"issue":"6","key":"10.1016\/j.suc.2020.02.009_bib9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","article-title":"Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma","volume":"153","author":"Alexander","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.suc.2020.02.009_bib10","series-title":"Report on carcinogens","author":"National Toxicology Program","year":"2011"},{"key":"10.1016\/j.suc.2020.02.009_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A\u00a0consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified delphi process","volume":"40","author":"Carr","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"20","key":"10.1016\/j.suc.2020.02.009_bib12","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","article-title":"Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study","volume":"28","author":"Elias","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"20","key":"10.1016\/j.suc.2020.02.009_bib14","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.suc.2020.02.009_bib15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1245\/ASO.2004.09.008","article-title":"Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials","volume":"11","author":"Elias","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib16","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.18_suppl.LBA3503","article-title":"A\u00a0UNICANCER phase III trial of hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7 (abstract)","volume":"36","author":"Quenet","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.suc.2020.02.009_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.suc.2020.02.009_bib18","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2020.02.009_bib19","series-title":"Sabiston textbook of surgery: the biological basis of modern surgical practice","author":"Townsend","year":"2017"},{"key":"10.1016\/j.suc.2020.02.009_bib20","series-title":"Management of peritoneal metastases- cytoreductive surgery, HIPEC and beyond","author":"Bhatt","year":"2018"},{"key":"10.1016\/j.suc.2020.02.009_bib21","series-title":"The Peritoneum","author":"DiZerega","year":"2012"},{"issue":"39","key":"10.1016\/j.suc.2020.02.009_bib22","doi-asserted-by":"crossref","first-page":"14371","DOI":"10.3748\/wjg.v20.i39.14371","article-title":"Peritoneal carcinomatosis of gastrointestinal tumors: where are we now?","volume":"20","author":"Terzi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.suc.2020.02.009_bib23","series-title":"Peritoneal Carcinomatosis: A Multidisciplinary Approach","author":"Ceelen","year":"2007"},{"issue":"2","key":"10.1016\/j.suc.2020.02.009_bib24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"issue":"39","key":"10.1016\/j.suc.2020.02.009_bib25","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.3748\/wjg.v18.i39.5489","article-title":"Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options","volume":"18","author":"Klaver","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.suc.2020.02.009_bib26","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1046\/j.1365-2168.2000.01553.x","article-title":"Clinical presentation of the pseudomyxoma peritonei syndrome","volume":"87","author":"Esquivel","year":"2000","journal-title":"Br J Surg"},{"key":"10.1016\/j.suc.2020.02.009_bib27","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1245\/s10434-013-3358-y","article-title":"Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis","volume":"21","author":"Magge","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib28","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ejso.2008.09.010","article-title":"Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma","volume":"35","author":"Yano","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00384-014-2029-1","article-title":"Advances in malignant peritoneal mesothelioma","volume":"30","author":"Cao","year":"2015","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.suc.2020.02.009_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/030089160308900307","article-title":"Clinical presentation of peritoneal mesothelioma","volume":"89","author":"Acherman","year":"2003","journal-title":"Tumori"},{"key":"10.1016\/j.suc.2020.02.009_bib31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/annonc\/mdp307","article-title":"Malignant peritoneal mesothelioma: a multicenter study on 81 cases","volume":"21","author":"Manzini Vde","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2018.07.003","article-title":"The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)","volume":"44","author":"Bushati","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib33","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1245\/s10434-010-1492-3","article-title":"Determining the association between preoperative computed tomography findings and post-operative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei","volume":"18","author":"Chua","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/jso.20049","article-title":"Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement","volume":"86","author":"de Bree","year":"2004","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","article-title":"Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis","volume":"16","author":"Koh","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib36","first-page":"530","article-title":"Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery","volume":"181","author":"Jacquet","year":"1995","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.suc.2020.02.009_bib37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jso.21601","article-title":"Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study","volume":"102","author":"Esquivel","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib38","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s00261-018-01888-y","article-title":"Mucinous appendiceal neoplasms: classification, imaging, and HIPEC","volume":"44","author":"Bartlett","year":"2019","journal-title":"Abdom Radiol (N Y)"},{"issue":"5","key":"10.1016\/j.suc.2020.02.009_bib39","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1245\/s10434-014-4041-7","article-title":"Comparison of MRI and CT for predicting the peritoneal cancer index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures","volume":"22","author":"Low","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.suc.2020.02.009_bib40","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/bjs.10527","article-title":"Evaluation of peritoneal carcinomatosis index with CT and MRI","volume":"104","author":"Dohan","year":"2017","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.suc.2020.02.009_bib41","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/02656736.2017.1366554","article-title":"Are positron emission tomography-computed tomography (PET-CT) scans useful in preoperative assessment of patients with peritoneal disease before cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)?","volume":"34","author":"Wang","year":"2018","journal-title":"Int J Hyperthermia"},{"issue":"8","key":"10.1016\/j.suc.2020.02.009_bib42","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/jso.23924","article-title":"Incorporation of diagnostic laparoscopy in the management algorithm for patients with peritoneal metastases: A multi-institutional analysis","volume":"111","author":"Tabrizian","year":"2015","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib43","first-page":"187","article-title":"Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mesothelioma","volume":"23","author":"Laterza","year":"2009","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.suc.2020.02.009_bib44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/bjs.8908","article-title":"Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis","volume":"100","author":"Iversen","year":"2013","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.suc.2020.02.009_bib45","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12885-019-5408-8","article-title":"Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial","volume":"19","author":"Bastiaenen","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.suc.2020.02.009_bib46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/gyno.2000.6036","article-title":"The role of laparoscopy in second-look evaluations for ovarian cancer","volume":"80","author":"Husain","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib47","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00268-006-0454-1","article-title":"Mucocele of the appendix","volume":"31","author":"Inoue","year":"2007","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.suc.2020.02.009_bib48","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2214\/AJR.08.1753","article-title":"Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings\u2014a feasibility study","volume":"193","author":"Low","year":"2009","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.suc.2020.02.009_bib49","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1245\/s10434-015-4624-y","article-title":"Age-related morbidity and mortality with cytoreductive surgery","volume":"22","author":"Peters","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib50","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1245\/s10434-013-3053-z","article-title":"Outcomes of Cytoreductive Surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality","volume":"20","author":"Votanopoulos","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib51","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1245\/s10434-016-5738-6","article-title":"Prognostic factors and significance of gastrointestinal leak after Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC)","volume":"24","author":"Chouliaras","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib52","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1245\/s10434-014-3987-9","article-title":"Peritoneal surface disease with synchronous hepatic involvement treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"22","author":"Randle","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib53","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.ejso.2009.07.005","article-title":"Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection","volume":"35","author":"Chua","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib54","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ejso.2004.01.017","article-title":"The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer","volume":"30","author":"Carmignani","year":"2004","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2020.02.009_bib55","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1245\/s10434-019-07518-1","article-title":"Improved survival with experience: a 10-year learning curve in hyperthermic intraperitoneal chemotherapy and cytoreductive surgery","volume":"27","author":"Leigh","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib56","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.suc.2020.02.009_bib57","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1245\/s10434-019-07415-7","article-title":"Preoperative nutrition status and postoperative outcomes in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"26","author":"Reece","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib58","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1475-2891-12-118","article-title":"The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy","volume":"12","author":"Vashi","year":"2013","journal-title":"Nutr J"},{"key":"10.1016\/j.suc.2020.02.009_bib59","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.clnu.2017.02.013","article-title":"ESPEN guideline: clinical nutrition in surgery","volume":"36","author":"Weimann","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.suc.2020.02.009_bib60","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1245\/s10434-019-07900-z","article-title":"Implementation of an Enhanced Recovery After Surgery (ERAS) Program is associated with improved outcomes in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"27","author":"Webb","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/jso.21322","article-title":"Perioperative management of patients with cytoreductive surgery for peritoneal carcinomatosis","volume":"100","author":"Schmidt","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.suc.2020.02.009_bib62","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5492\/wjccm.v6.i2.116","article-title":"Critical care management and intensive care unit outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"6","author":"Kapoor","year":"2017","journal-title":"World J Crit Care Med"},{"issue":"12","key":"10.1016\/j.suc.2020.02.009_bib63","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/jamasurg.2017.2865","article-title":"Association of fluid administration with morbidity in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"152","author":"Eng","year":"2017","journal-title":"JAMA Surg"},{"issue":"Suppl 3","key":"10.1016\/j.suc.2020.02.009_bib64","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1245\/s10434-019-07283-1","article-title":"ASO author reflections: intraoperative fluid restriction during CRS-HIPEC\u2014less is more","volume":"26","author":"Hendrix","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib65","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s11605-015-2743-1","article-title":"A\u00a0randomized trial of goal directed vs standard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"19","author":"Colantonio","year":"2015","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.suc.2020.02.009_bib66","doi-asserted-by":"crossref","first-page":"244","DOI":"10.21037\/jgo.2018.12.09","article-title":"Inflammatory response and optimalisation of perioperative fluid administration during hyperthermic intraoperative intraperitoneal chemotherapy surgery","volume":"10","author":"de Witte","year":"2019","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib67","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2044.2007.05380.x","article-title":"Perioperative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"63","author":"Schmidt","year":"2008","journal-title":"Anaesthesia"},{"key":"10.1016\/j.suc.2020.02.009_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2110-5820-1-1","article-title":"Hemodynamic parameters to guide fluid therapy","volume":"1","author":"Marik","year":"2011","journal-title":"Ann Intensive Care"},{"issue":"6","key":"10.1016\/j.suc.2020.02.009_bib69","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/sur.2018.250","article-title":"Increased incidence of central venous catheter-related infection in patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy","volume":"20","author":"Waters","year":"2019","journal-title":"Surg Infect (Larchmt)"},{"issue":"2","key":"10.1016\/j.suc.2020.02.009_bib70","first-page":"160","article-title":"Intra-abdominal pressure, cardiac index and vascular resistance during hyperthermic intraperitoneal chemotherapy: a prospective observational study","volume":"82","author":"Schluermann","year":"2016","journal-title":"Minerva Anestesiol"},{"issue":"1","key":"10.1016\/j.suc.2020.02.009_bib71","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1096-9098(199709)66:1<19::AID-JSO5>3.0.CO;2-Q","article-title":"Thoracic complications in patients undergoing intraperitoneal heated chemotherapy with mitomycin following cytoreductive surgery","volume":"66","author":"Chen","year":"1997","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib72","doi-asserted-by":"crossref","first-page":"635314","DOI":"10.1155\/2012\/635314","article-title":"Pulmonary complications following cytoreductive surgery and perioperative chemotherapy in 147 consecutive patients","volume":"2012","author":"Preti","year":"2012","journal-title":"Gastroenterol Res Pract"},{"issue":"3","key":"10.1016\/j.suc.2020.02.009_bib73","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4103\/ija.IJA_39_18","article-title":"Anaesthetic management and perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a retrospective analysis","volume":"62","author":"Balakrishnan","year":"2018","journal-title":"Indian J Anaesth"},{"key":"10.1016\/j.suc.2020.02.009_bib74","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/jso.21660","article-title":"Thoracic epidural anesthesia in patients with cytoreductive surgery and HIPEC","volume":"102","author":"Schmidt","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib75","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1477-7819-9-169","article-title":"Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC)","volume":"9","author":"Cooksley","year":"2011","journal-title":"World J Surg Oncol"},{"issue":"5","key":"10.1016\/j.suc.2020.02.009_bib76","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1245\/s10434-015-4963-8","article-title":"Routine admission to intensive care unit after cytoreductive surgery and heated intraperitoneal chemotherapy: not always a requirement","volume":"23","author":"Mogal","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib77","first-page":"307317","article-title":"Intensive care unit admission after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Is it necessary?","volume":"2014","author":"L\u00f3pez-Basave","year":"2014","journal-title":"J\u00a0Oncol"},{"issue":"6","key":"10.1016\/j.suc.2020.02.009_bib78","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ejso.2016.03.004","article-title":"No impact on long-term survival of prolonged ICU stay and re-admission for patients undergoing cytoreductive surgery with HIPEC","volume":"42","author":"Wallet","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.suc.2020.02.009_bib79","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.clnu.2006.01.015","article-title":"ESPEN guidelines on enteral nutrition: surgery including organ transplantation","volume":"25","author":"Weimann","year":"2006","journal-title":"Clin Nutr"},{"issue":"41","key":"10.1016\/j.suc.2020.02.009_bib80","doi-asserted-by":"crossref","first-page":"e5111","DOI":"10.1097\/MD.0000000000005111","article-title":"Short-term outcome in patients treated with cytoreduction and HIPEC compared to conventional colon cancer surgery","volume":"95","author":"Simkens","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.suc.2020.02.009_bib81","unstructured":"The ILEUS Study: a phase 2 randomized controlled trial investigating alvimopan for enhanced gastrointestinal recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03352414. Accessed October 31, 2019."},{"key":"10.1016\/j.suc.2020.02.009_bib82","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1245\/s10434-011-1820-2","article-title":"HIPEC for peritoneal carcinomatosis: does an associated urologic procedure increase morbidity?","volume":"19","author":"Honor\u00e9","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.suc.2020.02.009_bib83","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000339920","article-title":"Ureteral stenting in cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy as a routine procedure: evidence and necessity","volume":"89","author":"Coccolini","year":"2012","journal-title":"Urol Int"},{"key":"10.1016\/j.suc.2020.02.009_bib84","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/ijgc-2018-000099","article-title":"Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis","volume":"29","author":"Angeles","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.suc.2020.02.009_bib85","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1080\/02656736.2017.1368096","article-title":"Identification of risk factors associated with postoperative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a retrospective study","volume":"34","author":"Cata","year":"2018","journal-title":"Int J Hyperthermia"},{"issue":"6","key":"10.1016\/j.suc.2020.02.009_bib86","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ejso.2015.12.016","article-title":"Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignancies","volume":"42","author":"Arjona-S\u00e1nchez","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib87","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ejso.2016.09.008","article-title":"Best practice for perioperative management of patients with cytoreductive surgery and HIPEC","volume":"43","author":"Rasp\u00e9","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib88","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s12630-017-0952-7","article-title":"Coagulation after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a retrospective cohort analysis","volume":"64","author":"Hurdle","year":"2017","journal-title":"Can J Anaesth"},{"issue":"7","key":"10.1016\/j.suc.2020.02.009_bib89","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/jso.24746","article-title":"Factors associated with thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"116","author":"Rottenstreich","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib90","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1245\/s10434-019-07884-w","article-title":"ASO author reflections: venous thromboembolism after CRS\/HIPEC","volume":"26","author":"Baumgartner","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.suc.2020.02.009_bib91","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/sur.2016.102","article-title":"Infectious complications after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy","volume":"18","author":"Arslan","year":"2017","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.suc.2020.02.009_bib92","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1245\/ASO.2006.03.079","article-title":"Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy","volume":"13","author":"Sugarbaker","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.suc.2020.02.009_bib93","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1245\/s10434-018-6823-9","article-title":"Postoperative complications independently predict cancer-related survival in peritoneal malignancies","volume":"25","author":"Choudry","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.suc.2020.02.009_bib94","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3949\/ccjm.78a.10052","article-title":"Malignant bowel obstruction: individualized treatment near the end of life","volume":"78","author":"Soriano","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.suc.2020.02.009_bib95","first-page":"174","article-title":"Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma","volume":"3","author":"Ma","year":"1997","journal-title":"Cancer J Sci Am"},{"issue":"Suppl 1","key":"10.1016\/j.suc.2020.02.009_bib96","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jpainsymman.2007.04.011","article-title":"Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction","volume":"34","author":"Anthony","year":"2007","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"2","key":"10.1016\/j.suc.2020.02.009_bib97","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ijgc-00009577-200203000-00002","article-title":"Palliative management of malignant bowel obstruction","volume":"12","author":"Ripamonti","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.suc.2020.02.009_bib98","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11916-001-0040-z","article-title":"Modern management of cancer-related intestinal obstruction","volume":"5","author":"Davis","year":"2001","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.suc.2020.02.009_bib99","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0140-6736(85)90534-3","article-title":"Medical management of intestinal obstruction in patients with advanced malignant disease","volume":"2","author":"Baines","year":"1985","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.suc.2020.02.009_bib100","first-page":"611","article-title":"Malignant intestinal obstruction","volume":"87","author":"Osteen","year":"1980","journal-title":"Surgery"},{"key":"10.1016\/j.suc.2020.02.009_bib101","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/1097-0142(197002)25:2<406::AID-CNCR2820250219>3.0.CO;2-4","article-title":"Delayed intestinal obstruction following treatment for cancer","volume":"25","author":"Ketcham","year":"1970","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2020.02.009_bib102","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00268-013-2303-3","article-title":"Small bowel obstruction in patients with a prior history of cancer: predictive findings of malignant origins","volume":"38","author":"Denise","year":"2013","journal-title":"World J Surg"},{"key":"10.1016\/j.suc.2020.02.009_bib103","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/110241598750005688","article-title":"Small bowel obstruction in patients previously operated on for colorectal cancer","volume":"164","author":"Edna","year":"1998","journal-title":"Eur J Surg"},{"key":"10.1016\/j.suc.2020.02.009_bib104","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF02053685","article-title":"Small bowel obstruction after colon resection for benign and malignant diseases","volume":"34","author":"Ellis","year":"1991","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.suc.2020.02.009_bib105","first-page":"173","article-title":"Surgical management of intestinal obstruction in the late course of malignant disease","volume":"150","author":"Aabo","year":"1984","journal-title":"Acta Chir Scand"},{"issue":"8","key":"10.1016\/j.suc.2020.02.009_bib106","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ejca.2008.02.028","article-title":"Management of malignant bowel obstruction","volume":"44","author":"Ripamonti","year":"2008","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.suc.2020.02.009_bib107","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ejso.2018.12.015","article-title":"Acute malignant obstruction in patients with peritoneal carcinomatosis: The role of palliative surgery","volume":"45","author":"de Boer","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2020.02.009_bib108","article-title":"Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer","author":"Cousins","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.suc.2020.02.009_bib109","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jamasurg.2013.4059","article-title":"Palliative surgery for malignant bowel obstruction from carcinomatosis: a systematic review","volume":"149","author":"Paul Olson","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.suc.2020.02.009_bib110","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1053\/ejso.2001.1120","article-title":"Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction","volume":"27","author":"Legendre","year":"2001","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.suc.2020.02.009_bib111","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jjco\/hyg061","article-title":"Factors affecting successful palliative surgery for malignant bowel obstruction due to peritoneal dissemination from colorectal cancer","volume":"33","author":"Higashi","year":"2003","journal-title":"Japanese Journal of Clinical Oncology"},{"key":"10.1016\/j.suc.2020.02.009_bib112","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1200\/JCO.1989.7.3.381","article-title":"Results of surgery for obstructing carcinomatosis of gastrointestinal, pancreatic, or biliary origin","volume":"7","author":"Turnbull","year":"1989","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.suc.2020.02.009_bib113","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1572-0241.2004.40017.x","article-title":"Buckley MPooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction","volume":"99","author":"Sebastian","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.suc.2020.02.009_bib114","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1007\/s00464-011-1638-9","article-title":"Predictors of complications after endoscopic retrograde cholangiopancreatography: a prognostic model for early discharge","volume":"25","author":"Jeurnink","year":"2011","journal-title":"Surg Endosc"},{"issue":"1","key":"10.1016\/j.suc.2020.02.009_bib115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1996.0197","article-title":"Palliative treatment of upper intestinal obstruction by gynecological malignancy: the usefulness of percutaneous endoscopic gastrostomy","volume":"62","author":"Campagnutta","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.suc.2020.02.009_bib116","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11864-006-0046-1","article-title":"Decompressive percutaneous gastrostomy tube use in gynecologic malignancies","volume":"7","author":"Meyer","year":"2006","journal-title":"Curr Treat Options Oncol"},{"issue":"2","key":"10.1016\/j.suc.2020.02.009_bib117","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1072-7515(01)00980-2","article-title":"Laparoscopic continuous hyperthermic peritoneal perfusion","volume":"193","author":"Chang","year":"2001","journal-title":"J\u00a0Am Coll Surg"},{"issue":"6","key":"10.1016\/j.suc.2020.02.009_bib118","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ejso.2006.03.014","article-title":"Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites","volume":"32","author":"Garofalo","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.suc.2020.02.009_bib119","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejso.2007.05.015","article-title":"Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer","volume":"34","author":"Facchiano","year":"2008","journal-title":"Eur J Surg Oncol"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610920300220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610920300220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:10:58Z","timestamp":1758539458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610920300220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0039610920300220"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2020.02.009","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peritoneal Cancers and Hyperthermic Intraperitoneal Chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2020.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}